EARLY DIAGNOSTIC CRITERIA FOR CLINICAL MANIFESTATIONS OF VERTEBROGENIC PAIN SYNDROME IN CHILDHOOD AND ADOLESCENCE (LITERATURE REVIEW)
Keywords:
pain syndrome, vertebral neurology, childhood and adolescenceAbstract
The development of vertebro-neurology has been marked by significant progress in the study of pathogenesis, clinic and treatment of vertebrogenic diseases of the nervous system in adults. However, despite this, the incidence of diseases caused by degenerative-dystrophic processes in the spine is not only not decreasing, but on the contrary, is increasing. Perhaps this is due to insufficient prevention of vertebrogenic diseases of the nervous system. Between 30 and 60% of the population in developed countries suffer from recurrent back pain, and up to 80% of all back pain is in the lumbar back region. All ages can suffer from spinal pain, but the peak incidence is between 30 and 60 years of age. The currently used treatment protocols in the adult population, such severe forms of STS such as herniated intervertebral disc with concomitant radiculopathy, are not always effective.
References
Абдусаломова М., Ким О., Дусяров Ж. Оценка качества жизни у больных с дорсопатиями //Журнал вестник врача. – 2019. – Т. 1. – №. 4. – С. 7-10.
Абдусаломова М. А., Мавлянова З. Ф., Ким О. А. Орқа мия ва умуртқа поғонасининг бўйин қисмининг туғруқ жароҳатлари билан беморларнинг диагностикасида электронейромиографиянинг ўрни //журнал биомедицины и практики. – 2022. – Т. 7. – №. 2.
Левин О.С., Штульман Д.Р. Неврология. — М.: Медпресс-информ, 2016. — 1090 с.
Подчуфарова Е.В., Яхно Н.Н. Боль в спине. — М.: ГОЭТАР-Медиа, 2010 — 368 с.
Самиев А. С., Мавлянова З. Ф., Эрназаров А. Ж. Комплексная реабилитация больных с поясничными спондилогенными радикулопатиями //Science and Education. – 2023. – Т. 4. – №. 2. – С. 453-461.
Умирова С. М., Мавлянова З. Ф., Сабирова Ш. Б. Реабилитационные мероприятия при протрузии межпозвонковых дисков поясничного отдела позвоночника, у спортсменов занимающихся различными видами единоборства //Достижения науки и образования. – 2019. – №. 12 (53). – С. 68-71.
Утаганова Г. Х., Джурабекова А. Т., Мавлянова З. Ф. Натальные шейно-спондилогенные поражения (к оценке лечения задержки нервно-психического развития) //РМЖ. – 2009. – Т. 17. – №. 15. – С. 956-958.
Худойкулова Ф. В. и др. the structure, age features, and functions of hormones. pedagog, 1 (5), 681-688. – 2023.
Apkarian A., Robinson J. Low back pain // IASP Pain Clinical Updates 2010; XVIII (6): 1-6.
Chou R., Qaseem A., Snow V. Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society // Ann Intern Med 2007; 147: 478-491.
Chou R., Qaseem A, Owens D. Diagnostic Imaging for Low Back Pain: Advice for High-Value HealthCare From the American College of Physicians // Ann Intern Med 2011; 154: 181-189.
Cohen S., Raja S. Pathogenesis, Diagnosis, and Treatment of Lumbar Zygapophysial (Facet Joint Pain //Anesthesiology 2007; 106 (591-614).
McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis // Osteoarthr Cartil 2014; 22:363-88.
Dequeker J., Hawkey C., Kahan A. et al. Improvement in gastrointestinal tolerability on the selective cyclooхygenase (COX)-2 inhibitor me^icam, compared with piroхicam: results of the Safety and Efficacy Largescale Evalution of COX-inhibiting Therapies (SELECT) trial in osteoarthritis // Br. J. Rheumatol 1998; 37. (9): 946-951.
Mamasharifovich M. S. et al. Анкилозланувчи спондилоартрити бўлган беморлар реабилитация дастурига янгича ёндашув //journal of biomedicine and practice. – 2022. – Т. 7. – №. 1.
Yocum D., Fleishmann R., Dalgin P. et al. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12- week, double-blind, multiple doses, placebo-
controlled trial. The Meloxicam Osteoarthritis Investigators // Arch. Intern. Med 2000;. 160 (19): 2947-2954.
Lemmel E.M., Bolten W., Burgos-Vargas R. Efficacy and safety of meloxicam in patients with rheumatoid arthritis // J. Rheum 1997; 24 (2): 282-290.
Dougados M., Gueguen A., Nakache J.P. et al. Ankylosing spondilitis: what is the optimum duration of a clinical study? A one year versus 6 weeks non-steroidal anti-inflammatory drug trial // Rheumatology 1999; 38 (3): 235-244.
Grosser T., Fries S., FitzGerald G. Biological basis for the cardiovascular consequens of COX-2 inhibition: therapeutic challeges and opportunities // J. Clin. Invest 2006; 116: 4-15.
Altman R., Luciardi H.L., Muntaner J. et al. Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study // Circulation 2002; 106 (2): 191-195.
